JENSCARE-B(09877)

4.010+0.090+2.30%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
JENSCARE-B
Market
SEHK
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.jenscare.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Jenscare Scientific Co Ltd is a China-based company mainly engaged in the manufacturing and research and development of medical devices. The Company develops interventional products for the treatment of structural heart disease. The Company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The Company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. The Company mainly conducts its businesses in the domestic market.

1D
5D
Day
Week
Month

Loading ...

High

4.070

Open

3.970

Volume%

3.39

Low

3.920

Close

3.920

T/O Rate

0.10%

抱歉，当前请求异常(-1)

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"pagemeta":{"title":"JENSCARE-B(09877),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest JENSCARE-B(09877) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"JENSCARE-B,09877,JENSCARE-B股票,JENSCARE-B股票老虎,JENSCARE-B股票老虎国际,JENSCARE-B行情,JENSCARE-B股票行情,JENSCARE-B股价,JENSCARE-B股市,JENSCARE-B股票价格,JENSCARE-B股票交易,JENSCARE-B股票购买,JENSCARE-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"JENSCARE-B(09877),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest JENSCARE-B(09877) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"community","symbol":"09877","data":{"stockData":{"symbol":"09877","market":"HK","secType":"STK","nameCN":"JENSCARE-B","latestPrice":4.01,"timestamp":1742198899038,"preClose":3.92,"halted":0,"volume":294800,"delay":0,"floatShares":310000000,"shares":417167290,"eps":-0.9579956066697228,"marketStatus":"Not Yet Opened","change":0.09,"latestTime":"03-17 16:08:19","open":3.97,"high":4.07,"low":3.92,"amount":1185002,"amplitude":0.038265,"askPrice":4.09,"askSize":3400,"bidPrice":4.01,"bidSize":3400,"shortable":0,"etf":0,"ttmEps":-0.7724422671618714,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1742261400000},"marketStatusCode":0,"adr":0,"listingDate":1665331200000,"exchange":"SEHK","adjPreClose":3.92,"openAndCloseTimeList":[[1742175000000,1742184000000],[1742187600000,1742198400000]],"volumeRatio":3.393186007198282,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.343263386271904","cardData":[{"tweetId":"343263386271904","author":{"authorId":"4126759561094192","idStr":"4126759561094192","name":"4c003ce9","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":636,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"Jenscare 2024H1 Interim Result","digest":"Financial Highlights:&nbsp;Net Loss Narrowed Significantly with Solid Cash Balance Jenscare (9877.HK), an innovative medical device company dedicated to interventional treatment for structural heart diseases with TTVR breakthroughs, released interim results for 2024H1 ended June 30, 2024. Net Loss attributable to common shareholders was RMB 102 million[1] (US$ 14 million), narrowed down by 41.8% compared to the same period of last year. Cash[2] was RMB 922 million (US$ 129 million), which is sufficient for the future development of the Company to achieve its business strategy by advancing the global application of its Core Products, including carrying forward the clinical trial, the registration process, and market launch of the products. [1] Conversions from RMB to US$ is made at an excha","plainDigest":"Financial Highlights: Net Loss Narrowed Significantly with Solid Cash Balance Jenscare (9877.HK), an innovative medical device company dedicated to interventional treatment for structural heart diseases with TTVR breakthroughs, released interim results for 2024H1 ended June 30, 2024. Net Loss attributable to common shareholders was RMB 102 million[1] (US$ 14 million), narrowed down by 41.8% compared to the same period of last year. Cash[2] was RMB 922 million (US$ 129 million), which is sufficient for the future development of the Company to achieve its business strategy by advancing the global application of its Core Products, including carrying forward the clinical trial, the registration process, and market launch of the products. [1] Conversions from RMB to US$ is made at an excha","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1724822890606,"gmtModify":1724823940134,"symbols":["09877"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/e1aea23d9ba7ea6fce3697b9151fe267","width":"900","height":"383"}],"repostCount":0,"viewCount":223,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/343263386271904","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":6708,"displayRows":4,"strategy":"timeline","authorId":"4126759561094192"}]},{"cardType":"TWEET","cardId":"TWEET.260775537455296","cardData":[{"tweetId":"260775537455296","author":{"authorId":"4126759561094192","idStr":"4126759561094192","name":"4c003ce9","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":636,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"Jenscare (9877.HK) 2023Q4 Newsletter","digest":"Disclaimer The information disclosed in this article is for academic communication purposes only and should not be construed as medical advice under any circumstances. We make no representations or warranties as to the accuracy, completeness or timeliness of all original, reproduced or shared content.&nbsp; For any medical device mentioned in this article, our company does not make any commitment and guarantee on its performance and clinical performance in diagnosis and treatment activities. <a href=\"https://laohu8.com/S/09877\">$健世科技-B(09877)$</a>","plainDigest":"Disclaimer The information disclosed in this article is for academic communication purposes only and should not be construed as medical advice under any circumstances. We make no representations or warranties as to the accuracy, completeness or timeliness of all original, reproduced or shared content. For any medical device mentioned in this article, our company does not make any commitment and guarantee on its performance and clinical performance in diagnosis and treatment activities. $健世科技-B(09877)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1704676100471,"gmtModify":1704676105565,"symbols":["09877"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":2,"images":[],"repostCount":0,"viewCount":55,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/260775537455296","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":438,"displayRows":4,"strategy":"timeline","authorId":"4126759561094192"}]},{"cardType":"TWEET","cardId":"TWEET.230023884652552","cardData":[{"tweetId":"230023884652552","author":{"authorId":"4126759561094192","idStr":"4126759561094192","name":"4c003ce9","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":636,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"Jenscare(9877.HK) 2023Q3 Newsletter","digest":"Jenscare(9877.HK) 2023Q3 Newsletter Jenscare(9877.HK) 2023Q3 Newsletter <a href=\"https://laohu8.com/S/09877\">$健世科技-B(09877)$</a>","plainDigest":"Jenscare(9877.HK) 2023Q3 Newsletter Jenscare(9877.HK) 2023Q3 Newsletter $健世科技-B(09877)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1697178156252,"gmtModify":1697178156301,"symbols":["09877"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":5,"images":[{"url":"https://static.tigerbbs.com/91172e2bc68b12c19c6fc72b86200f4a","width":"4680","height":"6617"},{"url":"https://static.tigerbbs.com/6120501626fbbf7d78164deaf9f3498e","width":"4677","height":"6614"},{"url":"https://static.tigerbbs.com/0c3dec520778deb5681555cf809b2cd7","width":"4677","height":"6614"}],"repostCount":0,"viewCount":111,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/230023884652552","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":85,"displayRows":4,"strategy":"timeline","authorId":"4126759561094192"}]},{"cardType":"TWEET","cardId":"TWEET.198824096043032","cardData":[{"tweetId":"198824096043032","author":{"authorId":"4126759561094192","idStr":"4126759561094192","name":"4c003ce9","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":636,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"Jenscare 2023Q2 Newsletter","digest":"Jenscare(9877.HK) 2023Q2 Newsletter <a href=\"https://laohu8.com/S/09877\">$健世科技-B(09877)$</a>","plainDigest":"Jenscare(9877.HK) 2023Q2 Newsletter $健世科技-B(09877)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1689563688596,"gmtModify":1689563688636,"symbols":["09877"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":4,"images":[{"url":"https://static.tigerbbs.com/9882fe7111fb1b2fd02e17421935813f","width":"4680","height":"6617"},{"url":"https://static.tigerbbs.com/338d4f41f796a153b6aa7fe5a56db1d1","width":"4677","height":"6614"},{"url":"https://static.tigerbbs.com/a1a0a6849da6c81a45781d1f9196f3bb","width":"4677","height":"6614"}],"repostCount":0,"viewCount":59,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/198824096043032","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":52,"displayRows":4,"strategy":"timeline","authorId":"4126759561094192"}]}],"size":4,"extra":{"requestId":"ec5ef04b4e2c4661b1f78f1dbc24fbff"}},"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.jenscare.com","stockEarnings":[{"period":"1week","weight":0.0497},{"period":"1month","weight":-0.0452},{"period":"3month","weight":0.261},{"period":"6month","weight":0.8651},{"period":"1year","weight":-0.6374},{"period":"ytd","weight":0.2263}],"compareEarnings":[{"period":"1week","weight":0.0152},{"period":"1month","weight":0.0674},{"period":"3month","weight":0.2256},{"period":"6month","weight":0.3672},{"period":"1year","weight":0.444},{"period":"ytd","weight":0.2037}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Jenscare Scientific Co Ltd is a China-based company mainly engaged in the manufacturing and research and development of medical devices. The Company develops interventional products for the treatment of structural heart disease. The Company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The Company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. The Company mainly conducts its businesses in the domestic market.","exchange":"SEHK","name":"JENSCARE-B","nameEN":"JENSCARE-B"},"aProfile":null}}}